Rosario Pivonello

Endocrinology — Federico II University Hospital, Italy

LeadR Profile

Rosario Pivonello Federico II University Hospital Italy
2 215 ScienceLeadR Reputation 2215
Network Map

Endocrinology

Subspecialties: Public Health - Pharmacy - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Federico II University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The association between androgenic profile and cardiometabolic risk factors in young men: insights from a large observational cohort study.
endocrinology, blood, cardiometabolic risk factors, blood pressure, cohort studies, testosterone, cholesterol, prevalence, obesity, risk factors
J Endocrinol Invest20260
Prolactinomas in the transition from adolescence to young adulthood: A multicentre, retrospective study from the TALENT group.
prolactinoma, retrospective studies, cabergoline, hormones, adolescent, prolactin, diagnosis, therapeutics, nervous system
J Neuroendocrinol20260
Body mass index outperforms the Rotterdam criteria in defining phenotypic heterogeneity in polycystic ovary syndrome: a multicenter study from the Italian PCOS registry (PCOSOUTCOME.net).
registries, endocrinology, body mass index, androgens, ovary, phenotype, prevalence, obesity, polycystic ovary syndrome
J Endocrinol Invest20260
Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.
endocrinology, safety, hydrocortisone, cushing syndrome
J Clin Endocrinol Metab20260
Semen Quality in a Large Cohort of Males Living in Highly Polluted Areas of Campania Region in Southern Italy with a Focus on the Role of Cadmium Exposure.
fertility, endocrine disruptors, oligospermia, prevalence, teratozoospermia, environment, spermatozoa, smoking, asthenozoospermia
J Clin Med20260

Clinical Studies 28

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 10
Phase 2 7
N/A 5
Phase 4 4
Phase 2/Phase 3 2

By status:

Completed 18
Recruiting 4
Terminated 2
Unknown 2
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 23
Observational 5

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 2
multicentric5to9 2
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Evaluate Atumelnant in Adults with Congenital Adrenal Hyperplasia
2024-519579-24-00 — safety, adrenal hyperplasia, congenital, hyperplasia
Phase 3Not yet recruiting2026
A study to learn about the safety and effectiveness of CRN04894 on participants
2024-514846-35-00 — safety, adrenal hyperplasia, congenital, therapeutics, hyperplasia
Phase 2Recruiting2025
LOng COvid COmorbidities Andrological Reproductive Sexual Dysfunctions in Patients Recovered From COVID 19
NCT05379556 — premature ejaculation, research design, masturbation, quality of life, comorbidity, erectile dysfunction, sars-cov-2, life style, follicle stimulating hormone, body mass index, serum, estradiol, ageusia, body height, prostaglandins, prostate, physical examination, self-assessment, ejaculation, sexual abstinence, hormones, testosterone, anosmia, covid-19, prolactin, varicocele, prevalence, body weight, alprostadil, fires, wounds and injuries, plastics, testis, infections, post-acute covid-19 syndrome, female, male
N/ARecruiting2022
Rec LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
NCT04189133 — chorionic gonadotropin, hypogonadism, safety, luteinizing hormone, infertility, hormones, testosterone, gonadotropins, therapeutics, infertility, male, steroids, menotropins, male, men
Phase 2Recruiting2022

LeadR Networks

Main global connection map